1.62
price up icon11.72%   0.17
pre-market  Vorhandelsmarkt:  1.63   0.010   +0.62%
loading
Schlusskurs vom Vortag:
$1.45
Offen:
$1.46
24-Stunden-Volumen:
11.61M
Relative Volume:
1.30
Marktkapitalisierung:
$486.14M
Einnahmen:
$188.87M
Nettoeinkommen (Verlust:
$-400.38M
KGV:
-1.08
EPS:
-1.5
Netto-Cashflow:
$-260.90M
1W Leistung:
+12.50%
1M Leistung:
+27.56%
6M Leistung:
-10.50%
1J Leistung:
-10.00%
1-Tages-Spanne:
Value
$1.45
$1.63
1-Wochen-Bereich:
Value
$1.35
$1.63
52-Wochen-Spanne:
Value
$0.8511
$2.72

Pacific Biosciences Of California Inc Stock (PACB) Company Profile

Name
Firmenname
Pacific Biosciences Of California Inc
Name
Telefon
650-521-8000
Name
Adresse
1305 O'BRIEN DRIVE, MENLO PARK, CA
Name
Mitarbeiter
575
Name
Twitter
@pacbio
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
PACB's Discussions on Twitter

Vergleichen Sie PACB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
PACB
Pacific Biosciences Of California Inc
1.62 432.12M 188.87M -400.38M -260.90M -1.50
Medical Devices icon
ABT
Abbott Laboratories
125.73 228.77B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
103.16 153.09B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
395.15 149.27B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.65 114.31B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.30 45.06B 5.54B 4.18B 623.10M 7.00

Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-11 Herabstufung UBS Buy → Neutral
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-22 Herabstufung JP Morgan Overweight → Neutral
2024-04-18 Herabstufung Goldman Buy → Neutral
2023-12-14 Eingeleitet Guggenheim Neutral
2023-12-14 Eingeleitet Stephens Overweight
2023-12-13 Eingeleitet Wolfe Research Peer Perform
2023-11-17 Hochstufung UBS Neutral → Buy
2023-10-31 Hochstufung Cantor Fitzgerald Neutral → Overweight
2023-09-28 Eingeleitet Bernstein Outperform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-06-30 Eingeleitet Goldman Buy
2023-05-10 Eingeleitet Barclays Equal Weight
2023-03-31 Hochstufung TD Cowen Market Perform → Outperform
2023-02-02 Eingeleitet UBS Neutral
2023-01-20 Herabstufung Cantor Fitzgerald Overweight → Neutral
2023-01-05 Eingeleitet Scotiabank Sector Outperform
2022-01-21 Fortgesetzt Cantor Fitzgerald Overweight
2022-01-06 Fortgesetzt Piper Sandler Neutral
2021-10-15 Fortgesetzt Cowen Market Perform
2021-09-27 Eingeleitet Canaccord Genuity Buy
2021-02-11 Hochstufung Piper Sandler Neutral → Overweight
2020-11-03 Herabstufung Piper Sandler Overweight → Neutral
2020-10-02 Hochstufung JP Morgan Neutral → Overweight
2020-09-09 Eingeleitet Morgan Stanley Equal-Weight
2020-06-02 Fortgesetzt Cantor Fitzgerald Overweight
2020-03-09 Fortgesetzt Cantor Fitzgerald Overweight
2019-10-15 Hochstufung Piper Jaffray Neutral → Overweight
2019-04-02 Herabstufung Stephens Overweight → Equal-Weight
2018-10-19 Eingeleitet Cowen Outperform
2017-11-03 Herabstufung First Analysis Sec Overweight → Equal-Weight
2017-09-28 Herabstufung CL King Buy → Neutral
2016-11-03 Bestätigt Cantor Fitzgerald Buy
2016-06-27 Eingeleitet CL King Buy
2016-04-15 Eingeleitet First Analysis Sec Overweight
2016-02-04 Herabstufung Piper Jaffray Overweight → Neutral
2016-01-04 Bestätigt Cantor Fitzgerald Buy
2015-10-23 Hochstufung Piper Jaffray Neutral → Overweight
2015-08-27 Eingeleitet Cantor Fitzgerald Buy
2015-02-04 Bestätigt Maxim Group Buy
2013-09-26 Bestätigt Maxim Group Buy
2013-01-14 Bestätigt Maxim Group Buy
Alle ansehen

Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten

pulisher
02:33 AM

Is Pacific Biosciences of California Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional

02:33 AM
pulisher
Jul 22, 2025

What analysts say about Pacific Biosciences of California Inc. stockFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Pacific Biosciences of California Inc. stock priceRapid capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

QIAGEN launches long-read sequencing panels for complex genomic regions By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

PACB Stock Rally: Bullish Signs or Temporary Spike? - StocksToTrade

Jul 22, 2025
pulisher
Jul 22, 2025

Pacific Biosciences of California Inc. Stock Analysis and ForecastOutstanding capital returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 - Yahoo Finance

Jul 21, 2025
pulisher
Jul 17, 2025

Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Jul 17, 2025
pulisher
Jul 17, 2025

How long-read sequencing uncovers hitchhikers of the genomic galaxy in parasitic fungi - PacBio

Jul 17, 2025
pulisher
Jul 16, 2025

Pacific Biosciences Stock Jumps Amid Strategic Acquisitions - StocksToTrade

Jul 16, 2025
pulisher
Jul 16, 2025

Pacific Biosciences Sees Stock Uptick Following Strategic Moves - timothysykes.com

Jul 16, 2025
pulisher
Jul 11, 2025

Chromosome-level genome assembly with telomeric repeats at scaffold ends for Rhabdosargus sarba - Nature

Jul 11, 2025
pulisher
Jul 11, 2025

Here's Why You Should Add PacBio Stock to Your Portfolio Now - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Further Upside For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Could Introduce Price Risks After 29% Bounce - simplywall.st

Jul 11, 2025
pulisher
Jul 10, 2025

Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance

Jul 10, 2025
pulisher
Jul 09, 2025

Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jul 09, 2025
pulisher
Jul 04, 2025

PACB Stock Price and Chart — NASDAQ:PACB - TradingView

Jul 04, 2025
pulisher
Jul 03, 2025

Pacific Biosciences Sees Stock Surge After Latest Product Launch - timothysykes.com

Jul 03, 2025
pulisher
Jul 03, 2025

Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue - Insider Monkey

Jul 03, 2025
pulisher
Jul 02, 2025

Why PACB’s Stock is Rising? - StocksToTrade

Jul 02, 2025
pulisher
Jul 02, 2025

How the Long Read Sequencing Market Will Evolve by 2032Growth, - openPR.com

Jul 02, 2025
pulisher
Jun 30, 2025

The 5 Most Interesting Analyst Questions From PacBio’s Q1 Earnings Call - Yahoo Finance

Jun 30, 2025
pulisher
Jun 25, 2025

Barclays Adjusts Price Target for PacBio (PACB) Amid Funding Con - GuruFocus

Jun 25, 2025
pulisher
Jun 24, 2025

Third Generation Sequencing Market Set to Witness Significant - openPR.com

Jun 24, 2025
pulisher
Jun 21, 2025

Long Read Sequencing Market Projected to Reach USD 6.98 - GlobeNewswire

Jun 21, 2025
pulisher
Jun 12, 2025

Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Following a 41% decline over last year, recent gains may please Pacific Biosciences of California, Inc. (NASDAQ:PACB) institutional owners - simplywall.st

Jun 12, 2025
pulisher
Jun 12, 2025

Celebrating Father’s Day with new discoveries of the Y chromosome achieved with HiFi sequencing - PacBio

Jun 12, 2025
pulisher
Jun 11, 2025

Transcript : Pacific Biosciences of California, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 10 - MarketScreener

Jun 11, 2025
pulisher
Jun 10, 2025

PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds - Yahoo Finance

Jun 10, 2025
pulisher
Jun 06, 2025

Pacific Biosciences Approves Key Proposals at Annual Meeting - TipRanks

Jun 06, 2025
pulisher
Jun 05, 2025

Powered by PacBio: Selected publications from May 2025 - PacBio

Jun 05, 2025
pulisher
Jun 05, 2025

Pacific Biosciences Of California To Present At Jefferies Conference; Webcast At 8:45 AM ET - Nasdaq

Jun 05, 2025
pulisher
Jun 04, 2025

Amgen To Present At Jefferies Healthcare Conference; Webcast At 9:20 AM ET - Nasdaq

Jun 04, 2025
pulisher
Jun 04, 2025

Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment - Yahoo Finance

Jun 04, 2025
pulisher
Jun 02, 2025

Pacific Biosciences of California, Target ALS Collaborate for Genomic Study - marketscreener.com

Jun 02, 2025

Finanzdaten der Pacific Biosciences Of California Inc-Aktie (PACB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$285.57
price up icon 1.64%
medical_devices STE
$223.69
price up icon 0.47%
medical_devices PHG
$25.02
price up icon 1.96%
$85.12
price up icon 1.30%
$76.49
price up icon 3.14%
medical_devices EW
$76.30
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):